Why the study?
Does infusion of noradrenaline or vasopressin reduce PARP activation in a rat model of brain death?
Does infusion of noradrenaline or vasopressin reduce PARP activation in a rat model of brain death?
Appropriate donor resuscitation with noradrenaline or vasopressin can mitigate early cardiac graft damage by reducing PARP activation in a brain death model.
May inform vasopressor selection in brain-dead donors; leaves open translation to human cardiac graft outcomes.
DNA damage during transplantation can activate poly-adenosine diphosphate ribose polymerase (PARP) resulting in the generation of polymers of adenosine diphosphate-ribose (PAR). Excessive linkage of PAR to nuclear proteins can induce cell death, thereby limiting the function of transplanted organs. This study uses a rat model of brain death to determine the profile of PARP activation and whether mechanisms that lead to cell death can be ameliorated by appropriate donor resuscitation. The expression of PAR-linked nuclear proteins within cardiac myocytes was greatly increased after the induction of donor brain death. Importantly, infusion of noradrenaline or vasopressin to normalize the chronic hypotension produced by brain death reduced the expression of PAR to a level below baseline. These data suggest that chronic hypotension after donor brain death has the potential to limit cardiac function through the activation of PARP; however, this early cause of graft damage can be mitigated by appropriate donor resuscitation.
No takes yet. Share an insight, caveat, or question.
Brain et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: